FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Apr. 2, 2018--
MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Children’s
Urology Associates, P.A., a private pediatric urology practice based in
Miami.
Children’s Urology was established in 1999 and employs six physicians,
all fellowship trained in pediatric urology, as well as four physician
assistants and advanced registered nurse practitioners. The practice
provides consult, surgery, cystoscopy, circumcision, ultrasound and
urinalysis services to children. It is both office and hospital-based in
three counties (Miami-Dade, Broward and Palm Beach), servicing Baptist
Children's Hospital, Broward Health Medical Center, Jackson Memorial
Hospital, Kendall Regional Medical Center, Joe DiMaggio Children’s
Hospital, Nicklaus Children's Hospital and Miami Children’s Ambulatory
Surgery Center, West Boca Medical Center and South Miami Hospital. In
association with the Nicklaus Children’s Health System and the
University of Miami Leonard M. Miller School of Medicine, Children’s
Urology participates in the urology residency training program and runs
the only Accreditation Council for Graduate Medical Education (ACGME)
accredited fellowship training program for pediatric urology in Florida.
“Partnering with MEDNAX’s national network provides a unique opportunity
to continue to grow our practice in South Florida and solidify our
position in an ever-changing and complex health care environment,” said
Rafael Gosalbez, M.D., who will serve as medical director for the
practice. “MEDNAX has previously invested locally in pediatric urology,
which will facilitate the coordination of care for pediatric patients
with the most complex urological disorders. Additionally, MEDNAX has a
proven record on outcomes research, and we plan to continue and enhance
our own research and educational efforts through this valuable
partnership.”
This acquisition adds to the services MEDNAX provides in Florida through
its affiliated network of physicians across multiple specialties which
include anesthesiology, maternal-fetal medicine, neonatology, newborn
hearing screens, obstetric hospitalist, pediatric cardiology, pediatric
hospitalist, pediatric intensive care and radiology.
This was a cash transaction and it is expected to be immediately
accretive to earnings. No additional terms of the transaction were
disclosed.
With this acquisition, four physician group practices have become part
of MEDNAX in 2018.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner based in Sunrise,
Fla. comprised of the nation's leading providers of physician services.
Physicians and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, clinical research and telemedicine to enhance patient
outcomes and provide high-quality, cost-effective care. The Company was
founded in 1979, and today, through its affiliated professional
corporations, MEDNAX provides services through a network of
approximately 4,075 physicians in all 50 states and Puerto Rico. In
addition to its national physician network, MEDNAX provides services to
healthcare facilities and physicians in over 40 states through two
complementary businesses, consisting of a revenue cycle management
company and a consulting services company. Additional information is
available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180402005210/en/
Source: MEDNAX, Inc.
MEDNAX, Inc.
Charles Lynch, 954-384-0175 ext. 5692
Vice
President, Strategy and Investor Relations
charles_lynch@mednax.com